Literature DB >> 6718484

Biliary excretion of acetaminophen in ureter-ligated rats.

C P Siegers, C D Klaassen.   

Abstract

Over one fourth (28.4%) of a 100 mg/kg intravenous dose of acetaminophen (AA) is excreted into bile of conscious rats within 8 h. The main metabolite in bile was the glucuronide (14.3%), followed by the sulfate (8.2%), the glutathione conjugate (4.7%) and unchanged AA (1.2%). In rats with bilateral ligation of the ureters, the amount of total AA excreted into bile was significantly increased to 37.8% of the dose; this enhanced excretion was a consequence of augmented amounts of glucuronide (20.3%) and sulfate (12.0%) whereas the amount of the glutathione conjugate in bile was slightly diminished (4.2%). During renal failure, increased biliary elimination of AA conjugates, mainly as the sulfate, seems to partially compensate the lack of renal excretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6718484     DOI: 10.1159/000137959

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Effects of biliary cannulation and buthionine sulphoximine pretreatment on the nephrotoxicity of para-aminophenol in the Fischer 344 rat.

Authors:  K P Gartland; C T Eason; F W Bonner; J K Nicholson
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.